General Information:

Id: 8,674
Diseases: Metabolic
Rattus norvegicus
article/cited
Reference: [PMID: 7395984]

Interaction Information:

Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 90079

gene/protein

AMP deaminase

decreases_quantity of

drug/chemical compound

AMP

Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 90080

gene/protein

AMP deaminase

increases_quantity of

drug/chemical compound

IMP

Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 90081

gene/protein

AMP deaminase

increases_quantity of

drug/chemical compound

NH3

Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 90189

gene/protein

Adenylosuccinate synthetase

increases_quantity of

drug/chemical compound

Adenylosuccinate

Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 90190

gene/protein

Adenylosuccinate synthetase

decreases_quantity of

drug/chemical compound

IMP

Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 90194

gene/protein

Adenylosuccinate synthetase

decreases_quantity of

drug/chemical compound

Aspartate

Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 90195

gene/protein

Adenylosuccinate synthetase

decreases_quantity of

drug/chemical compound

GTP

Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 90196

gene/protein

ADSL

decreases_quantity of

drug/chemical compound

Adenylosuccinate

Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 90200

gene/protein

ADSL

increases_quantity of

drug/chemical compound

Fumarate

Drugbank entries Show/Hide entries for
Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 90201

gene/protein

ADSL

increases_quantity of

drug/chemical compound

AMP

Comment Fumarate produced during reamination of IMP to AMP catalyzed by ADSL, could supply 4-carbon intermediates to support the Krebs cycle during accelerated aerobic metabolism. (cited information)
Formal Description
Interaction-ID: 90203

drug/chemical compound

Fumarate

increases_activity of

Drugbank entries Show/Hide entries for Fumarate
Comment AMP deaminase is activated by accumulation of ADP, AMP or by decreasing pH.
Formal Description
Interaction-ID: 90205

drug/chemical compound

AMP

increases_activity of

gene/protein

AMP deaminase

Comment AMP deaminase is activated by accumulation of ADP, AMP or by decreasing pH.
Formal Description
Interaction-ID: 90206

phenotype

acidosis

increases_activity of

gene/protein

AMP deaminase

Comment AMP deaminase is activated by accumulation of ADP, AMP or by decreasing pH.
Formal Description
Interaction-ID: 90207

drug/chemical compound

ADP

increases_activity of

gene/protein

AMP deaminase

Comment Hadacidin is a competitive inhibitor of aspartate binding to adenylosuccinate synthetase, thereby inhibiting IMP reamination.
Formal Description
Interaction-ID: 90208

drug/chemical compound

Hadacidin

decreases_activity of

gene/protein

Adenylosuccinate synthetase

in fast muscle
Drugbank entries Show/Hide entries for Hadacidin
Comment Adenylosuccinate synthetase activity is inhibited by GDP, ADP, AMP, and IMP.
Formal Description
Interaction-ID: 90210

drug/chemical compound

GDP

decreases_activity of

gene/protein

Adenylosuccinate synthetase

in fast muscle
Comment Adenylosuccinate synthetase activity is inhibited by GDP, ADP, AMP, and IMP.
Formal Description
Interaction-ID: 90211

drug/chemical compound

ADP

decreases_activity of

gene/protein

Adenylosuccinate synthetase

in fast muscle
Comment Adenylosuccinate synthetase activity is inhibited by GDP, ADP, AMP, and IMP.
Formal Description
Interaction-ID: 90212

drug/chemical compound

AMP

decreases_activity of

gene/protein

Adenylosuccinate synthetase

in fast muscle
Comment Adenylosuccinate synthetase activity is inhibited by GDP, ADP, AMP, and IMP.
Formal Description
Interaction-ID: 90213

drug/chemical compound

IMP

decreases_activity of

gene/protein

Adenylosuccinate synthetase

in fast muscle
Comment AMP deaminase is inhibited under resting conditions.
Formal Description
Interaction-ID: 90221

environment

resting condition

decreases_activity of

gene/protein

AMP deaminase

in skeletal muscle
Comment Gastrocnemius and plantaris muscles were stimulated tetanically for 3 min and allowed to recover in situ for 30 min. This intense stimulation results in conversion of about half the total adenine nucleotide pool (chiefly ATP) to IMP, which is subsequently reaminated during the recovery period. The concentration of ammonia and lactate increases as well. IMP and ammonia accumulate under rigorous tetanic contractions.
Formal Description
Interaction-ID: 90227

increases_quantity of

drug/chemical compound

IMP

in skeletal muscle
Comment Gastrocnemius and plantaris muscles were stimulated tetanically for 3 min and allowed to recover in situ for 30 min. This intense stimulation results in conversion of about half the total adenine nucleotide pool (chiefly ATP) to IMP, which is subsequently reaminated during the recovery period. IMP and ammonia accumulate under rigorous tetanic contractions. The concentration of ammonia and lactate increases as well.
Formal Description
Interaction-ID: 90229

decreases_quantity of

drug/chemical compound

ATP

in skeletal muscle
Comment Gastrocnemius and plantaris muscles were stimulated tetanically for 3 min and allowed to recover in situ for 30 min. This intense stimulation results in conversion of about half the total adenine nucleotide pool (chiefly ATP) to IMP, which is subsequently reaminated during the recovery period. IMP and ammonia accumulate under rigorous tetanic contractions. The concentration of ammonia and lactate increases as well.
Formal Description
Interaction-ID: 90231

increases_quantity of

drug/chemical compound

NH3

in skeletal muscle
Comment Gastrocnemius and plantaris muscles were stimulated tetanically for 3 min and allowed to recover in situ for 30 min. This intense stimulation results in conversion of about half the total adenine nucleotide pool (chiefly ATP) to IMP, which is subsequently reaminated during the recovery period. IMP and ammonia accumulate under rigorous tetanic contractions. The concentration of ammonia and lactate increases as well.
Formal Description
Interaction-ID: 90232

increases_quantity of

drug/chemical compound

Lactate

in skeletal muscle
Comment The level of AMP deaminase is much higher in fast muscles than the level of the other two enzymes of the purine nucleotide pathway, adenylosuccinate synthetase and adenylosuccinate lyase. This suggests that the rate of IMP reamination might be negligible relative to the rate of IMP formation during intense stimulation.
Formal Description
Interaction-ID: 90234

increases_activity of

gene/protein

AMP deaminase

in skeletal muscle
Comment The level of AMP deaminase is much higher in fast muscles than the level of the other two enzymes of the purine nucleotide pathway, adenylosuccinate synthetase and adenylosuccinate lyase. This suggests that the rate of IMP reamination might be negligible relative to the rate of IMP formation during intense stimulation.
Formal Description
Interaction-ID: 90237

decreases_activity of

gene/protein

Adenylosuccinate synthetase

in skeletal muscle
Comment The level of AMP deaminase is much higher in fast muscles than the level of the other two enzymes of the purine nucleotide pathway, adenylosuccinate synthetase and adenylosuccinate lyase. This suggests that the rate of IMP reamination might be negligible relative to the rate of IMP formation during intense stimulation.
Formal Description
Interaction-ID: 90238

decreases_activity of

gene/protein

ADSL

in skeletal muscle
Comment AMP deaminase is activated by ADP and AMP and inhibited by GTP and phosphate. This explains, why AMP deamination occurs to a significant extent in fast muscle only when the capacity for generation of ATP by aerobic metabolism is exceeded by the rate of ATP utlization. (cited information)
Formal Description
Interaction-ID: 90307

drug/chemical compound

Phosphate

decreases_activity of

gene/protein

AMP deaminase

in skeletal muscle
Comment AMP deaminase is activated by ADP and AMP and inhibited by GTP and phosphate. This explains, why AMP deamination occurs to a significant extent in fast muscle only when the capacity for generation of ATP by aerobic metabolism is exceeded by the rate of ATP utlization. (cited information)
Formal Description
Interaction-ID: 90310

drug/chemical compound

GTP

decreases_activity of

gene/protein

AMP deaminase

in skeletal muscle
Comment Lactate accumulation due to intense muscle work might result in a decrease of intracellular pH. Low pH contributes to the activation of AMP deaminase. (cited information)
Formal Description
Interaction-ID: 90312

drug/chemical compound

Lactate

increases_activity of

phenotype

acidosis

in skeletal muscle
Comment AMP deamination may also contribute to the control of glycolysis in fast muscle by supplying ammonium ion, an activator of phosphofructokinase. (cited information)
Formal Description
Interaction-ID: 90313

drug/chemical compound

NH3

increases_activity of

gene/protein

PFKM

in skeletal muscle
Comment AMP deamination may also contribute to the control of glycolysis in fast muscle by supplying ammonium ion, an activator of phosphofructokinase. (cited information)
Formal Description
Interaction-ID: 90316

gene/protein

PFKM

increases_activity of

in skeletal muscle
Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 90352

drug/chemical compound

AMP

increases_quantity of

drug/chemical compound

IMP

via AMP deaminase
Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 90353

drug/chemical compound

IMP

increases_quantity of

drug/chemical compound

Adenylosuccinate

via adenylosuccinate synthetase
Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 90354

drug/chemical compound

Adenylosuccinate

increases_quantity of

drug/chemical compound

AMP

via adenylosuccinate lyase
Comment AMP deamination may also contribute to the control of glycolysis in fast muscle by supplying ammonium ion, an activator of phosphofructokinase. (cited information)
Formal Description
Interaction-ID: 91239

gene/protein

Phosphofructokinase

increases_activity of

in skeletal muscle
Comment AMP deamination may also contribute to the control of glycolysis in fast muscle by supplying ammonium ion, an activator of phosphofructokinase. (cited information)
Formal Description
Interaction-ID: 91240

drug/chemical compound

NH3

increases_activity of

gene/protein

Phosphofructokinase

in skeletal muscle
Comment Adenosine 5'-monophosphate (AMP) deaminase, an enzyme of the IMP salvage pathway, catalyzes the irreversible deamination of AMP to IMP and ammonia. IMP may be reaminated to AMP by adenylosuccinate synthetase (catalyzing the reaction IMP+aspartate+GTP to adenylosuccinate+GDP+phosphate) and adenylosuccinate lyase (catalyzing the reaction adenylosuccinate to AMP+fumarate). (cited information)
Formal Description
Interaction-ID: 91574

drug/chemical compound

Aspartate

increases_quantity of

drug/chemical compound

Fumarate

via adenylosuccinate synthetase and -lyase
Drugbank entries Show/Hide entries for